Publication | Open Access
A MET Targeting Antibody–Drug Conjugate Overcomes Gemcitabine Resistance in Pancreatic Cancer
33
Citations
28
References
2021
Year
Together, these results suggest the promise of agents such as TR1801-ADC as a novel approach to the treatment of pancreatic cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1